Hemodialysis removes protective metabolites and disrupts mitochondrial function
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfaf145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von María Peris-Fernández und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Research Institute Hospital La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Renal Dialysis, Mitochondria, Metabolome, Kidney Failure, Chronic. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Nephrology Department of La Fe Hospital.
Abstract (Originalsprache)
Background
Metabolic analyses offer valuable insights into the biochemical changes induced by hemodialysis, yet prior studies have focused on targeted approaches or lacked comprehensive pathway analysis. This study employs semi-targeted metabolomics to explore metabolic shifts in hemodialysis patients.
Methods
Pre- and post-dialysis plasma samples were collected from 43 hemodialysis patients and analyzed using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Principal component analysis and orthogonal partial least squares discriminant analysis were used to assess metabolic separation, and variable importance in projection scores ranked the most significant metabolites.
Results
Hemodialysis significantly altered the plasma metabolome, with 79 metabolites showing relevant changes. Most were reduced, including harmful solutes like 3-indoxyl sulfate (fold change: 0.29-fold) and d-galactonic acid (0.14-fold), but also protective compounds such as l-carnitine (0.38-fold), quinic acid (0.16-fold) and homocarnosine (0.15-fold). Meanwhile, lipotoxic intermediates like myristic acid (2.51-fold) and linoleic acid (2.28-fold) increased. Enrichment analysis revealed disruptions in amino acid, lipid and energy metabolism, underscoring the dual impact of dialysis on both toxic and beneficial metabolites.
Conclusions
Hemodialysis alters the plasma metabolome by removing toxins but also depleting protective metabolites and promoting lipotoxic intermediates. These shifts may undermine therapy benefits, highlighting the need for strategies that preserve metabolic homeostasis in dialysis patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Research Institute Hospital La Fe, Valencia, Spain.
- Nephrology Department, University and Polytechnic La Fe Hospital, Valencia, Spain.
Förderung
- Nephrology Department of La Fe Hospital
Zitieren
APA
Peris-Fernández, M., Roca-Marugán, M. I., Viejo-Boyano, I., Soldevila-Orient, A., Devesa-Such, R., Sánchez-Pérez, P., & Hernández-Jaras, J. (2025). Hemodialysis removes protective metabolites and disrupts mitochondrial function. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf145
Vancouver
Peris-Fernández M, Roca-Marugán MI, Viejo-Boyano I, Soldevila-Orient A, Devesa-Such R, Sánchez-Pérez P, et al. Hemodialysis removes protective metabolites and disrupts mitochondrial function. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf145
BibTeX
@article{PerisFernndez2025,
author = {Peris-Fernández, María and Roca-Marugán, Marta Isabel and Viejo-Boyano, Iris and Soldevila-Orient, Amparo and Devesa-Such, Ramon and Sánchez-Pérez, Pilar and Hernández-Jaras, Julio},
title = {Hemodialysis removes protective metabolites and disrupts mitochondrial function},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfaf145}
}
EUVIMED